CISI FIN(06058) subsidiary purchases perpetual securities with a total principal amount of 13 million US dollars.

16:57 19/03/2026

CINDA International (06058) announced that its indirect wholly-owned subsidiary CISI Investment has purchased perpetual securities with a principal amount of USD 13 million (equivalent to approximately HKD 102 million) in the open market from January 28, 2026 to March 18, 2026. The total cost was approximately USD 14.22 million (equivalent to approximately HKD 112 million).

CISI FIN (06058) announces that its indirect wholly-owned subsidiary, CISI Investment, purchased perpetual securities with a principal amount of $13 million (equivalent to approximately HK$102 million) in the open market from January 28, 2026 to March 18, 2026, at a total cost of approximately $14.22 million (equivalent to approximately HK$112 million).

Novo Nordisk A/S Sponsored ADR Class B (NVO.US) plans to expand its weight loss drug market in Japan, targeting the blue ocean of self-paying patients with a "curve entry" strategy.

MIRAMAR HOTEL(00071): Wong Yeung Fong appointed as a member of the nomination committee

RSUN PPT(01996): Request for Hearing Extension to October 5th.

Novo Nordisk A/S Sponsored ADR Class B (NVO.US) plans to expand its weight loss drug market in Japan, targeting the blue ocean of self-paying patients with a "curve entry" strategy.

MIRAMAR HOTEL(00071): Wong Yeung Fong appointed as a member of the nomination committee

RSUN PPT(01996): Request for Hearing Extension to October 5th.